We are live on
!
Find out more
B
Bellecapital Portfolio holdings
AUM
$625M
Turnover
41.45%
1-Year Est. Return
39.69%
This Fund
S&P 500
This Quarter
Est. Return
+5.95%
1 Year Est. Return
+39.69%
3 Year Est. Return
+127.77%
5 Year Est. Return
+155.51%
10 Year Est. Return
+530.96%
AUM
$114M
AUM Growth
+$5.96M
(+5.5%)
Cap. Flow
+$1.42M
Cap. Flow
% of AUM
1.24%
Top 10 Holdings %
Top 10 Hldgs %
48.81%
Holding
78
New
3
Increased
13
Reduced
18
Closed
7
Avg Time Held
1.5
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
1.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$5.07M |
| 2 |
WisdomTree Japan Hedged Equity Fund
DXJ
|
+$2.66M |
| 3 |
State Street SPDR S&P International Small Cap ETF
GWX
|
+$1.51M |
| 4 |
JD.com
JD
|
+$970K |
| 5 |
Alibaba
BABA
|
+$778K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$3.22M |
| 2 |
Cisco
CSCO
|
+$2.07M |
| 3 |
Pfizer
PFE
|
+$1.03M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$991K |
| 5 |
McKesson
MCK
|
+$851K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.97% |
| 2 | Consumer Discretionary | 16.41% |
| 3 | Healthcare | 15.86% |
| 4 | Communication Services | 14.66% |
| 5 | Technology | 12.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
iShares Currency Hedged MSCI Japan ETF
HEWJ
$640M
| $1.22M | 1.07% |
41,000
| – | – |
2017 Q1
1 quarter
|
|
27
State Street SPDR S&P 500 ETF Trust
SPY
$815B
| $1.12M | 0.98% |
4,645
-1,319
| -22% | -$316K |
2015 Q4
6 quarters
|
|
28
ExxonMobil
XOM
$718B
| $1.11M | 0.98% |
13,790
| – | – |
2013 Q4
14 quarters
|
|
29
IBM
IBM
$221B
| $884K | 0.77% |
6,009
+219
| +4% | +$33K |
2016 Q2
4 quarters
|
|
30
DuPont de Nemours
DD
$17.8B
| $838K | 0.73% |
5,248
| – | – |
2016 Q3
3 quarters
|
|
31
RTX Corp
RTX
$252B
| $741K | 0.65% |
9,648
| – | – |
2013 Q4
14 quarters
|
|
32
State Street SPDR S&P China ETF
GXC
$445M
| $732K | 0.64% |
8,200
| – | – |
2016 Q4
2 quarters
|
|
33
Vanguard High Dividend Yield ETF
VYM
$81.4B
| $713K | 0.62% |
9,120
| – | – |
2013 Q4
14 quarters
|
|
34
McDonald's
MCD
$172B
| $689K | 0.6% |
4,500
| – | – |
2013 Q4
14 quarters
|
|
35
AbbVie
ABBV
$501B
| $683K | 0.6% |
9,416
-388
| -4% | -$26.1K |
2016 Q2
4 quarters
|
|
|
36
Procter & Gamble
PG
$365B
| $674K | 0.59% |
7,730
-36,492
| -83% | -$3.22M |
2013 Q4
14 quarters
|
|
37
Walmart Inc
WMT
$935B
| $651K | 0.57% |
25,809
-2,754
| -10% | -$69.9K |
2015 Q4
6 quarters
|
|
38
iShares Core S&P Mid-Cap ETF
IJH
$123B
| $611K | 0.54% |
17,575
| – | – |
2016 Q4
2 quarters
|
|
39
JPMorgan Chase
JPM
$891B
| $509K | 0.45% |
5,567
| – | – |
2014 Q3
11 quarters
|
|
40
Gilead Sciences
GILD
$195B
| $442K | 0.39% |
6,250
| – | – |
2016 Q4
2 quarters
|
|
41
Intel
INTC
$504B
| $437K | 0.38% |
12,960
| – | – |
2017 Q1
1 quarter
|
|
42
Microsoft
MSFT
$4.01T
| $436K | 0.38% |
6,325
| – | – |
2016 Q1
5 quarters
|
|
43
United Natural Foods
UNFI
$2.91B
| $415K | 0.36% |
11,300
| – | – |
2015 Q1
9 quarters
|
|
44
iShares MSCI United Kingdom ETF
EWU
$3.77B
| $400K | 0.35% |
+12,000
| New | +$403K |
2017 Q2
0 quarters
|
|
|
RDS.A
45
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $381K | 0.33% |
7,155
-122
| -2% | -$6.48K |
2016 Q3
3 quarters
|
|
46
DELISTED
Telefonica
TEF
| $368K | 0.32% |
43,848
| – | – |
2016 Q2
4 quarters
|
|
47
iShares Global Clean Energy ETF
ICLN
$2.14B
| $352K | 0.31% |
41,130
| – | – |
2013 Q4
14 quarters
|
|
48
Sanofi
SNY
$96.5B
| $352K | 0.31% |
7,340
| – | – |
2017 Q1
1 quarter
|
|
49
Vodafone
VOD
$36.7B
| $331K | 0.29% |
11,510
| – | – |
2016 Q4
2 quarters
|
|
50
Mattel
MAT
$4.95B
| $318K | 0.28% |
14,758
+27
| +0.2% | +$610 |
2013 Q4
14 quarters
|
|
Similar funds
TAM
RIP
CWM
LWP
FGA
BVC
APM
PIM
Bellecapital's Q2 2017 Portfolio in Review
As of Q2 2017, Bellecapital held 78 positions worth $114M, up 5.5% from $108M the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Bellecapital's Q2 2017 filing shows 3 new, 13 increased, 18 reduced and 7 closed positions. Its largest new stake was PRA Health Sciences, Inc.: 73,180 shares worth $5.49M. The largest sale was Procter & Gamble, an estimated $3.22M.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Bellecapital's largest Q2 2017 buy was PRA Health Sciences, Inc.: 73,180 shares worth $5.49M.
- Bellecapital added most to WisdomTree Japan Hedged Equity Fund in Q2 2017, an estimated $2.66M increase.
- Bellecapital's biggest Q2 2017 reduction was Procter & Gamble, cutting an estimated $3.22M.
- Bellecapital fully exited Pfizer in Q2 2017, selling an estimated $1.03M.
- Bellecapital's ten largest holdings make up 49% of its $114M portfolio in Q2 2017.
- Bellecapital opened 3 new positions and closed 7 in Q2 2017.
- Bellecapital's portfolio value rose 5.5% quarter-over-quarter to $114M.
Based on Bellecapital's 13F filing for Q2 2017, filed 26 Jul 2017.